Genscript Biotech Corporation (HKG:1548)
12.36
+0.51 (4.30%)
Apr 2, 2026, 4:08 PM HKT
Genscript Biotech Employees
Genscript Biotech had 6,165 employees as of December 31, 2025. The number of employees increased by 597 or 10.72% compared to the previous year.
Employees
6,165
Change (1Y)
597
Growth (1Y)
10.72%
Revenue / Employee
1.21M HKD
Profits / Employee
-672.71K HKD
Market Cap
27.03B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 6,165 | 597 | 10.72% | 6,165 | 0 |
| Dec 31, 2024 | 5,568 | -1,369 | -19.73% | 5,568 | 0 |
| Dec 31, 2023 | 6,937 | 724 | 11.65% | 6,937 | 0 |
| Dec 31, 2022 | 6,213 | 953 | 18.12% | 6,213 | 0 |
| Dec 31, 2021 | 5,260 | 659 | 14.32% | 5,255 | 5 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Shanghai Henlius Biotech | 3,762 |
| Shanghai Junshi Biosciences | 2,903 |
| Zai Lab | 1,784 |
| Keymed Biosciences | 1,625 |
| Biocytogen Pharmaceuticals (Beijing) | 1,306 |
| InnoCare Pharma | 1,176 |
| Ascentage Pharma Group International | 605 |
| Ascletis Pharma | 208 |
Genscript Biotech News
- 20 days ago - GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth - PRNewsWire
- 20 days ago - Genscript Biotech Corp (GNNSF) Full Year 2025 Earnings Call Highlights: Record Revenue Growth ... - GuruFocus
- 20 days ago - Full Year 2025 Genscript Biotech Corp Earnings Call Transcript - GuruFocus
- 8 months ago - GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation - PRNewsWire
- 8 months ago - GenScript Biotech's MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader - PRNewsWire
- 1 year ago - GenScript Biotech Corporation Reports FY 2024 Results - PRNewsWire
- 1 year ago - The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development - PRNewsWire
- 1 year ago - GenScript Biotech Sets Up New Operations and Logistics Hub in Sydney, Australia - PRNewsWire